Authors

Michael Chuong, Miami Cancer InstituteFollow

Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas

Publication Date

9-1-2024

Content Type

Article

PubMed ID:

38492812

Additional Authors:

Additional authors and institutional affiliations

Citation

Tchelebi, L. T., Segovia, D., Smith, K., Shi, Q., Fitzgerald, T. J., Chuong, M. D., Zemla, T. J., O'Reilly, E. M., Meyerhardt, J. A., Koay, E. J., Lowenstein, J., Shergill, A., Katz, M. H. G., & Herman, J. M. (2024). Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas. International journal of radiation oncology, biology, physics, 120(1), 111–119. https://doi.org/10.1016/j.ijrobp.2024.03.013